Omega-3 fatty acids in prevention of atrial fibrillation after open heart surgery - Omega-3 in postop a. fib.
- Conditions
- Atrial fibrillation after open heart surgery
- Registration Number
- EUCTR2004-002226-21-IS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Open heart surgery, including coronary artery bypass and valvular operations
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Age below 50 years of age.
History of atrial fibrillaton.
Use of amiodarone or sotalol.
Acute surgery.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To evaluate whether the perioperative administration of omega-3 polyunsaturated fatty acids can prevent the occurrence of atrial fibrillaton following open heart surgery. ;Secondary Objective: ;Primary end point(s): Atrial fibrillation in the period following the open heart surgery until hospital discharge
- Secondary Outcome Measures
Name Time Method